Abstract:Objective The authors’ goals were to determine whether baseline dopamine activity contributes to response to methylphenidate and to assess the pattern of metabolic responses associated with enhanced dopamine activity. Method They used positron emission tomography with 2-deoxy-2 [18F] fluoro-D-glucose to evaluate the effects of two sequential doses of methylphenidate on brain metabolism in 15 healthy subjects. Dopamine D2 receptor availability was measured with [11C] raclopride to evaluate its relation to methylphenidate-induced metabolic changes. Results Methylphenidate increased brain metabolism in six subjects, decreased it in two, and did not change it in seven; however, it consistently increased cerebellar metabolism. Methylphenidate significantly increased “relative”(region relative to the whole brain) metabolism in the cerebellum and decreased it in the basal ganglia. Regional metabolic changes in the cerebellum and the frontal and temporal cortices were significantly correlated with D2 availability. Frontal and temporal metabolism were increased in subjects with high D2 receptors and decreased in subjects with low D2 receptors. Conclusions Methylphenidate induced variable changes in brain metabolism, but it consistently increased cerebellar metabolism. It also induced a significant reduction in relative metabolism in the basal ganglia. The significant association between metabolic changes in the frontal and temporal cortices and in the cerebellum and D2 receptors suggests that methylphenidate’s metabolic effects in these brain regions are due in part to dopamine changes and that differences in D2 receptors may be …

Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma

Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D2receptors

Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors

Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies

Behavioral and cardiovascular effects of intravenous methylphenidate in normal subjects and cocaine abusers

Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects

Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain

Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications

Time-varying SUVr Reflects the Dynamics of Dopamine Increases During Methylphenidate Challenges in Humans.

Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

Methylphenidate decreases regional cerebral blood flow in normal human subjects

Is methylphenidate like cocaine?: Studies on their pharmacokinetics and distribution in the human brain

Dopamine Release in Dissociable Striatal Subregions Predicts the Different Effects of Oral Methylphenidate on Reversal Learning and Spatial Working Memory

Mechanism of action of methylphenidate: insights from PET imaging studies

Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain

Prediction of Reinforcing Responses to Psychostimulants in Humans by Brain Dopamine D2 Receptor Levels

Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction

Methylphenidate attenuates limbic brain inhibition after cocaine-cues exposure in cocaine abusers

Methylphenidate Enhances Working Memory by Modulating Discrete Frontal and Parietal Lobe Regions in the Human Brain

Methylphenidate enhances brain activation and deactivation responses to visual attention and working memory tasks in healthy controls